Author

Laura M. Williamson

BC Cancer AgencyORCID 0000-0001-7353-6533Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:database / resource· 2 Organism:human· 2 Research Focus:variant calling· 2 Assay:whole-genome sequencing· 2 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Cameron J. GrisdaleiD· 2 shared Eleanor Lewis· 2 shared Eric Chuah· 2 shared Erin PleasanceiD· 2 shared Janessa J. LaskiniD· 2 shared Jessica NelsoniD· 2 shared Marco A. MarraiD· 2 shared Stephen S. F. YipiD· 2 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Cameron J. GrisdaleORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicineCell GenomicsPeer-reviewedOct 14, 2024

Long-read sequencing of an advanced cancer cohort resolves rearrangements, unravels haplotypes, and reveals methylation landscapes

Kieran O’Neill, Erin Pleasance, Jeremy Fan…·Steven J.M. Jones

This paper presents a long-read sequencing dataset of cancer samples, showing its ability to resolve structural variants, haplotypes, and methylation patterns in precision medicine.

42 citationstop 1%

humanwhole-genome sequencing

𝕏 PostBluesky

BioinformaticsNature CommunicationsPeer-reviewedFeb 9, 2022

A Platform for Oncogenomic Reporting and Interpretation

Caralyn Reisle, Laura M. Williamson, Erin Pleasance…·Steven J.M. Jones

PORI is an open-source platform for interpreting somatic variants in cancer, demonstrating that 88.2% of TCGA tumors have at least one potentially targetable alteration.

18 citations

humanwhole-exome sequencing

𝕏 PostBluesky